Overview

This trial is active, not recruiting.

Condition depression
Treatment pharmacotherapeutic follow-up
Sponsor Federal University of São Paulo
Start date March 2010
End date March 2012
Trial size 60 participants
Trial identifier NCT01571973, SPPsicobio1Lu

Summary

The study examines whether pharmacotherapeutic follow-up improves outcomes of treatment of depressed outpatients.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification efficacy study
Intervention model parallel assignment
Masking open label
Primary purpose supportive care
Arm
(No Intervention)
outpatients receiving usual care
(Experimental)
outpatients receiving pharmaceutical care or pharmacotherapeutic follow-up by 6 months
pharmacotherapeutic follow-up
health education adjustment of dose improve compliance replacement of medication

Primary Outcomes

Measure
depression level
time frame: six months

Secondary Outcomes

Measure
anxiety level
time frame: 6 months
compliance
time frame: 6 months

Eligibility Criteria

Female participants from 18 years up to 65 years old.

Inclusion Criteria: - women between 18 and 65 years, with diagnostic hypothesis of depression at the beginning of treatment or change in treatment unless 2 months (dosage or substance) Exclusion Criteria: - record of dependence on psychoactive substances, diagnosed schizophrenia, - low education (illiterate) or cognitive impairment evident that compromise the completion of research instruments

Additional Information

Official title EVALUATION OF THE EFFECTIVENESS OF PHARMACEUTICAL CARE (DÁDER PROGRAM) IN DEPRESSED OUTPATIENTS TREATED WITH PSYCHOTROPIC
Trial information was received from ClinicalTrials.gov and was last updated in April 2012.
Information provided to ClinicalTrials.gov by Federal University of São Paulo.